Multiplexed Mass Spectrometry Assay Identifies Neurodegeneration Biomarkers in CSF

Home > Science Hub > Multiplexed Mass Spectrometry Assay Identifies Neurodegeneration Biomarkers in CSF
Back to the list

June 9, 2017

Pascal Croteau¹, Fiona McAllister¹, Laura McIntosh¹, Laetitia Cortes¹, Michael Schirm¹, Howard Schulman¹, Jane Paulsen², Daniel Chelsky¹. ¹Caprion Biosciences Inc, Montreal, Canada; ²The University of Iowa, Iowa City, IA.

Multiplexed Mass Spectrometry Assay Identifies Neurodegeneration Biomarkers in CSF, CNS Summit 2017

Multiplexed Mass Spectrometry Assay Identifies Neurodegeneration Biomarkers in CSF

Download poster

You might also be interested by

Brochures

Cell Therapy

December 15, 2023

Histopathology

More info

Brochures

Immuno-MRM Assays

August 4, 2023

Proteomics/Mass Spectrometry

More info

Webcasts & Webinars

Precision Oncology Approaches: Using Proteomics to Build Next-Gen Diagnostic Solutions

May 2, 2023

Proteomics/Mass Spectrometry

More info

Posters

Analytical characterization of a multiplex panel measuring 45 cytokines by proximity extension assay in plasma from subjects with NSCLC

April 17, 2023

Proteomics/Mass Spectrometry

More info